Combination Adjuvants Enhance Recombinant H5 Hemagglutinin Vaccine Protection Against High-Dose Viral Challenge in Chickens

Combination Adjuvants Enhance Recombinant H5 Hemagglutinin Vaccine Protection Against High-Dose Viral Challenge in Chickens

Background: Recombinant avian influenza subunit vaccines often require adjuvants to enhance immune responses. This study aims to evaluate the immune-enhancing potential of seven combination adjuvants in specific pathogen-free (SPF) chickens. Methods: SPF chickens were vaccinated with combinations of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanjuan He, Jiaxin Wang, Lanyan Chi, Yajing Dong, Huixin Chen, Xiaocui Meng, Ming Liao, Yongwen Luo, Huiying Fan
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Vaccines
Subjects:	avian influenza H5 subtype adjuvanted vaccine Quil-A TLR agonist
Online Access:	https://www.mdpi.com/2076-393X/12/12/1448
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Saponins and their role as vaccine adjuvant against coccidiosis in poultry
by: Abdullah F. ALSAYEQH
Published: (2025-06-01)

H9 Consensus Hemagglutinin Subunit Vaccine with Adjuvants Induces Robust Mucosal and Systemic Immune Responses in Mice by Intranasal Administration
by: Liming Lin, et al.
Published: (2024-11-01)

Multivalent COBRA Hemagglutinin and Neuraminidase Influenza Vaccines Adjuvanted with TLR9 Agonist CpG 1018
by: Pedro L. Sanchez, et al.
Published: (2025-06-01)

Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype
by: Shuxia Zhang, et al.
Published: (2025-04-01)

RARE INFLUENZA VIRUS SUBTYPES ISOLATED FROM BIRDS OF THE SOUTH OF WESTERN SIBERIA
by: M. V. Sivay, et al.
Published: (2012-09-01)

Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks
by: Yubo Zhao, et al.
Published: (2024-12-01)

Detection of Avian Influenza Virus in Pigeons
by: Ning Cui, et al.
Published: (2025-04-01)

Adjunctive beneficial effect of c-di-GMP, a STING agonist, in enhancing protective efficacy of TLR4-adjuvanted tuberculosis subunit vaccine formulations
by: Kee Woong Kwon, et al.
Published: (2025-05-01)

Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens
by: Kairat Tabynov, et al.
Published: (2025-03-01)

PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS
by: A. A. Nikonova, et al.
Published: (2019-07-01)

Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses
by: Sasan Fereidouni, et al.
Published: (2023-12-01)

Characterization of H9N2 avian influenza virus isolated from chickens and waterfowl in parts of Southern China from 2018 to April 2024
by: Wanting Zhou, et al.
Published: (2025-10-01)

Characterization of the avian influenza viruses distribution in the environment of live poultry market in China, 2019–2023
by: Hong Bo, et al.
Published: (2025-05-01)

Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
by: Yongqiang Zhao, et al.
Published: (2025-01-01)

Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines
by: Allegra Peletta, et al.
Published: (2024-07-01)

Agonists of Receptors of the Innate Immunity and Defective Viral Particles as New Generation of Adjuvants
by: O. A. Svitich, et al.
Published: (2018-02-01)

Corrigendum: Preliminary results on novel adjuvant combinations suggest enhancement immunogenicity of whole inactivated pandemic influenza vaccines
by: Allegra Peletta, et al.
Published: (2024-12-01)

Lipoprotein Signal Peptide as Adjuvants: Leveraging Lipobox-Driven TLR2 Activation in Modern Vaccine Design
by: Muhammad Umar, et al.
Published: (2025-01-01)

МORBIDITY OF INFLUENZA AND ACUTE VIRAL INFECTION IN YAKUTIA DURING EPIDEMIC SEASONS
by: I. Yu. Samojlova, et al.
Published: (2018-04-01)

Construction of a replication-defective recombinant virus and cell-based vaccine for H9N2 avian influenza virus
by: Lijin Lai, et al.
Published: (2025-07-01)

Hemagglutinin glycosylation pattern-specific effects: implications for the fitness of H9.4.2.5-branched H9N2 avian influenza viruses
by: Yixue Sun, et al.
Published: (2024-12-01)

Differential Adjuvant Activity by Flagellins from <i>Escherichia coli</i>, <i>Salmonella enterica</i> Serotype Typhimurium, and <i>Pseudomonas aeruginosa</i>
by: Shengmei Pang, et al.
Published: (2024-10-01)

Progress Update on STING Agonists as Vaccine Adjuvants
by: Yanru Shen, et al.
Published: (2025-03-01)

Choice of adjuvant drug therapy on the basis of the molecular classification of breast cancer
by: N. S. Besova
Published: (2014-07-01)

Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01)

PAIVS: prediction of avian influenza virus subtype
by: Hyeon-Chun Park, et al.
Published: (2020-03-01)

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
by: Fatima Amanat, et al.
Published: (2019-01-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage
by: Dexin Kong, et al.
Published: (2024-12-01)

Genetic characterization and receptor binding analysis of a novel H5N1 HPAI virus with a H6Nx-derived PA gene in Guangdong, China
by: Jieheng He, et al.
Published: (2024-12-01)

Incursion of Novel Eurasian Low Pathogenicity Avian Influenza H5 Virus, Australia, 2023
by: Michelle Wille, et al.
Published: (2024-12-01)

Recent developments of vaccines for older adults: Adjuvants and beyond
by: Luca Pangrazzi, et al.
Published: (2025-12-01)

A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine
by: Timothy S. Vincent, et al.
Published: (2024-11-01)

Identification of key antigenic sites in hemagglutinin of H10N3 avian influenza virus
by: Zhimin Wan, et al.
Published: (2024-12-01)

Thiopental-Dexmedetomidine as Adjuvant Anesthesia for Craniotomy Tumor Removal: A Case Report
by: Dewi Yulianti Bisri, et al.
Published: (2025-06-01)

Immunogenicity of a novel HMT13 adjuvant-based inactivated vaccine against Avian pathogenic Escherichia coli serogroups O36, O78, and O109
by: Chaoying Jia, et al.
Published: (2025-06-01)

Advance in chicken coccidiosis vaccine and its adjuvant
by: DU Ai-fang, et al.
Published: (2009-01-01)

The immunostimulatory activity of Epimedium flavonoids involves toll-like receptor 7/8
by: Jingyu Wu, et al.
Published: (2025-04-01)

Revisiting Avian Metapneumovirus Subtype B in Broiler Chickens and Turkeys in Morocco: First Molecular Characterization
by: Amine Mernizi, et al.
Published: (2024-12-01)

Risk assessment of the newly emerged H7N9 avian influenza viruses
by: Pengxiang Chang, et al.
Published: (2023-12-01)